amoxicillin
/ Generic mfg.
- LARVOL DELTA
Home
Next
Prev
1 to 25
Of
8078
Go to page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
March 26, 2026
Different Amoxicillin Treatment Regimens in Erythema Migrans Patients
(clinicaltrials.gov)
- P3 | N=200 | Recruiting | Sponsor: University Medical Centre Ljubljana | Phase classification: P=N/A ➔ P3 | N=510 ➔ 200
Enrollment change • Phase classification • Dermatology • Lyme Disease
March 20, 2026
DEPLETION OF GUT MICROBIOTA ALLEVIATES PROTEINURIA IN PUROMYCIN AMINONUCLEOSIDE-INDUCED NEPHROSIS IN RATS
(ISN-WCN 2026)
- "Rats were divided into three groups (n=6 each): a control group (oral PBS for 10 days followed by a single subcutaneous injection of PAN (50 mg/kg) on day 0, an antibiotic-treated group (oral amoxicillin, cefotaxime, vancomycin, and metronidazole) for 10 days, followed by PAN injection on day 0, and an indoxyl sulfate (IS)-treated group (antibiotics for 10 days followed by intraperitoneal IS and PAN injection on day 0). The protective effects of antibiotics were associated with the loss of indole-producing bacteria and reduced urinary IS, suggesting that pathogenic gut-derived metabolites drive podocyte injury. Targeting indole-producing bacteria or their metabolites may represent a novel therapeutic approach for MCNS, potentially reducing reliance on corticosteroids."
Gut Microbiota • Preclinical • Chronic Kidney Disease • Glomerulonephritis • Nephrology • Renal Disease
March 25, 2026
Optimized green zinc oxide/chitosan/amoxicillin nanocomposite against Pseudomonas aeruginosa.
(PubMed, Appl Microbiol Biotechnol)
- "These findings demonstrate that the ZnO/CS/AMX nanocomposite acts through a synergistic, multimodal mechanism, effectively overcoming bacterial resistance and biofilm recalcitrance, while also exhibiting favorable biocompatibility. KEY POINTS: RSM-Box-Behnken optimized green biosynthesis of ZnO NPs using cell-free metabolites of P. aeruginosaGreen synthesis of zinc oxide/chitosan/amoxicillin nanocomposite to combat MDR P. aeruginosaThe nanocomposite markedly enhances bactericidal and antibiofilm efficacy at low doses with high mammalian cell safety and synergistic action."
Journal • Infectious Disease
March 25, 2026
Dramatic increase in consumption of antibiotics in Colombia, 2020-2023.
(PubMed, Biomedica)
- "The progressive increase in consumption and spending on antimicrobials in Colombia requires a set of interventions that include promoting changes in medical prescribing behaviour and a public education campaign that leads to the adoption of a sustainable public health policy."
Journal
March 25, 2026
Emerging Antimicrobial Resistance in Klebsiella pneumoniae: A Molecular and Antibiogram Insight From the Beef Value Chain in Bangladesh.
(PubMed, Microbiologyopen)
- "The antibiogram profile depicted diverse resistance patterns with the highest resistance pattern to ampicillin (100%), amoxicillin (100%), and cefoxitin (87.12%). Phenotypic characterization, utilizing Congo red agar and microtiter plate tests, identified 25 out of 132 (19%) isolates as biofilm producers, with 7 (28%) classified as strong producers, and 3 (12%) and 15 (60%) as intermediate and weak producers, respectively. This study addresses the alarming emergence of antimicrobial resistance within the beef value chain in Bangladesh, posing an alarming threat to food safety and public health associated with biofilm-producing foodborne pathogens, underscoring the necessity for improved hygiene practices to mitigate the public health risk posed by these pathogens."
Journal • Infectious Disease • Pneumonia
March 25, 2026
Antibiotic prescribing and antimicrobial resistance: An evaluation of clinical teachers' knowledge, attitude and practices at a South African dental school.
(PubMed, PLoS One)
- "The results reveal a range of knowledge, attitudes, and practices related to antibiotic prescribing and AMR awareness among clinical teachers, and indicate acceptable levels of knowledge and practice in various clinical scenarios, however certain identified prescribing practices may require targeted educational intervention. By strengthening antibiotic stewardship principles among clinical teachers, undergraduate prescribing practices can be further enhanced."
Journal • Allergy • Immunology
March 25, 2026
Dual-layer tissue scaffolds with antibacterial and regenerative properties: Integration of melt electrowriting and electrospray technologies.
(PubMed, J Pharm Sci)
- "The paper discusses the development of dual-layer tissue scaffolds (DLS) using poly (lactic acid) (PLA) and amoxicillin (AMOX) nanoparticles at different concentrations (0.5% w/v and 1% w/v)...MTT assays confirmed cytocompatibility of the scaffold, showing enhanced cell viability for the DLS-0.05 AMOX scaffold. Considering the obtained results, dual-layer tissue scaffolds with antibacterial properties present significant potential for a wide range of wound care applications."
Journal
March 25, 2026
Comparison of Adverse Events Associated With Six Common Antibiotics in Lower Respiratory Tract Infections Using the United States Food and Drug Administration Adverse Event Reporting System.
(PubMed, Cureus)
- "Ciprofloxacin exhibited the highest reporting proportion, with 89 of 809 patients (11.0%), followed by clarithromycin (129/1,572; 8.2%), azithromycin (132/2,048; 6.4%), amoxicillin (90/1,796; 5.0%), levofloxacin (198/4,604; 4.3%), and doxycycline (26/693; 3.8%). Fluoroquinolones (levofloxacin, ciprofloxacin) and macrolides (clarithromycin, azithromycin) showed elevated serious AE reporting relative to amoxicillin, underscoring the need for careful benefit-risk assessment. These drug‑specific patterns and temporal characteristics may help inform targeted clinical monitoring and guide future pharmacoepidemiological research to verify these hypothesis‑generating findings."
Adverse events • Journal • CNS Disorders • Infectious Disease • Nephrology • Pulmonary Disease • Renal Disease • Respiratory Diseases
February 04, 2026
In vitro analysis of biofilm formation and synergistic antibiotic-phage therapy for amoxicillin-resistant Escherichia coli
(ESCMID Global 2026)
- No abstract available
Preclinical
February 04, 2026
Prevalence of dual resistance of Helicobacter pylori to clarithromycin and amoxicillin and emergence of novel genetic mutations among clinical isolates from adult patients with gastritis in Tehran, Iran, 2023–2024
(ESCMID Global 2026)
- No abstract available
Clinical • Gastrointestinal Disorder • Infectious Disease
February 04, 2026
A hit with a scar: amoxicillin alters the infant gut microbiome long-term but without fungal expansion
(ESCMID Global 2026)
- No abstract available
Gastrointestinal Disorder
February 04, 2026
Amoxicillin dosages in adult patients with streptococcal endocarditis: a PK/PD reappraisal
(ESCMID Global 2026)
- No abstract available
Clinical • PK/PD data • Cardiovascular
February 04, 2026
Unpredictable amoxicillin exposure under high-dose therapy: evidence supporting individualised-guided TDM
(ESCMID Global 2026)
- No abstract available
Clinical
February 04, 2026
Treatment of early Lyme borreliosis with amoxicillin for ten vs 14 days: a randomised open-label clinical trial
(ESCMID Global 2026)
- No abstract available
Clinical • Inflammatory Arthritis • Lyme Disease
February 04, 2026
Lack of synergy between amoxicillin and cefazolin against Enterococcus faecalis: reassessment of a proposed empirical regimen for infective endocarditis
(ESCMID Global 2026)
- No abstract available
Cardiovascular
February 04, 2026
Klebsiella pneumoniae hypervirulent clonal complex 66 among amoxicillin-susceptible strains
(ESCMID Global 2026)
- No abstract available
Infectious Disease • Pneumonia
March 20, 2026
Green manufacturing of amoxicillin trihydrate: a malic acid-assisted crystallization framework enhanced by Taguchi-ANN optimization.
(PubMed, RSC Adv)
- "Under optimized conditions (2.5 M malic acid, pH 5.5, 60 min, 1500 rpm), AMCT crystals were obtained with 99.21% purity and 61.82% yield. These results demonstrate a robust, data-driven framework for sustainable AMCT production, providing a high-performance alternative to conventional mineral-acid-based crystallization methods."
Journal
March 20, 2026
Microbial contamination of ART culture media with Enterococcus faecalis: case report of a live birth following blastocyst transfer.
(PubMed, Reprod Biomed Online)
- "Treatment with prophylactic amoxicillin resulted in a healthy live birth from a blastocyst contaminated with E. faecalis, questioning the systematic discarding of embryos from contaminated culture medium."
Journal
March 20, 2026
Amoxicillin and copper affect humification during compost: Insight into dissolved organic matter and bacterial community succession.
(PubMed, Environ Res)
- "During the cooling period, the complex pollution inhibited amino acid metabolism and carbohydrate metabolism, and suppressed the expression of GHs and GTs. This study provides data support for regulating HA formation during composting under combined pollution."
Journal
March 20, 2026
Ornamental coral pests and parasites: a biosecurity alert for aquarium trade.
(PubMed, Braz J Biol)
- "Chemical treatments (e.g., levamisole, praziquantel, KCl, milbemycin, amoxicillin) show partial efficacy, yet many are limited to adult stages and risk disrupting coral microbiota. In an era of climate change and increasing demand for captive-bred corals, integrating science-based management with aquarist practices is essential. Preventive measures, rapid diagnostics, and biotechnological innovation will be key to ensuring coral health and advancing the aquarium hobby as a tool for marine conservation."
Journal • Review
March 20, 2026
Case Report: Diagnosis and detection of amoxicillin-induced immune hemolytic anemia.
(PubMed, Front Immunol)
- "A combination of detailed drug history, serological testing, and drug-specific assays is essential for accurate diagnosis. Immediate withdrawal of the implicated drug remains critical for clinical recovery."
Journal • Anemia • Hematological Disorders
March 20, 2026
Salmonella Osteomyelitis with Cutaneous Fistula in an Immunocompetent Adult Presenting as a Tumor-Like Bone Lesion: A case report.
(PubMed, Intern Med)
- "The patient was treated with ceftriaxone and de-escalated to ampicillin, followed by oral amoxicillin. This case demonstrates that chronic osteomyelitis caused by NTS can present as a cutaneous fistula. Furthermore, it underscores the importance of obtaining a bone culture to identify the causative organism and ensure an accurate diagnosis."
Journal • Gastroenterology • Gastrointestinal Disorder • Infectious Disease • Inflammation • Oncology • Pain
March 20, 2026
Prevalence of Inducible Clindamycin Resistance Staphylococcus aureus Associated with Wound Infection in Central Nepal.
(PubMed, J Nepal Health Res Counc)
- "A high rate of inducible clindamycin resistance among MRSA was observed. To identify the status of antibiotic resistance among S. aureus, further genomic-based studies are required."
Journal • Infectious Disease
March 20, 2026
A 5-year review of Helicobacter pylori isolated from gastric biopsies at the UK Health Security Agency Gastrointestinal Bacteria Reference Unit.
(PubMed, J Med Microbiol)
- "Antimicrobial susceptibility to metronidazole, clarithromycin, levofloxacin, amoxicillin and tetracycline was determined phenotypically by E-test.Results. There is an urgent need to establish UK primary resistance rates in treatment-naïve patients to support a review of regional first-line treatment regimes. These results support a need for rapid, local isolation of H. pylori by clinical microbiology laboratories to maximize patient benefit due to delays in testing, significantly reducing the likelihood of recovering viable strains for susceptibility testing, and demonstrate that implementation of molecular tests could support better patient management."
Journal • Gastric Cancer • Infectious Disease • Oncology • Peptic Ulcer
March 21, 2026
FORMaT-EVOLVE: Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial
(clinicaltrials.gov)
- P2 | N=300 | Not yet recruiting | Sponsor: The University of Queensland
New P2 trial • Cystic Fibrosis • Genetic Disorders • Immunology • Infectious Disease • Nontuberculous Mycobacterial Disease • Pulmonary Disease • Respiratory Diseases
1 to 25
Of
8078
Go to page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324